Survival and quality of life in gastrointestinal tumors: Two different end points?

Annals of Oncology

Volumn 12, Issue SUPPL. 3, 2001, Pages

  Cascinu, S ^a   Labianca, R ^b   Daniele, B ^c   Beretta, G ^b   Salvagni, S ^a  

^a UNIVERSITY HOSPITAL OF PARMA   (Italy)

^b Azienda Ospedaliera di Bergamo   (Italy)

^c NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Gastrointestinal cancers; Quality of life

Indexed keywords

ACETIC ACID; ALCOHOL; ANTINEOPLASTIC AGENT; CAPECITABINE; CISPLATIN; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; FLUOROURACIL; FOLINIC ACID; GEMCITABINE; IRINOTECAN; LEVAMISOLE; MITOMYCIN C; OXALIPLATIN; RALTITREXED; UFT;

ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; COLORECTAL CANCER; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; HUMAN; LIFE EXPECTANCY; LIVER CANCER; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER RESECTION; LIVER TRANSPLANTATION; MEDICAL ASSESSMENT; METHODOLOGY; OUTCOMES RESEARCH; PANCREAS CANCER; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; STOMACH CANCER; STOMACH SURGERY; SYMPTOM; TREATMENT CONTRAINDICATION;

EID: 0035664532     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/12.suppl_3.S31     Document Type: Article

References (57)

1. Il trattamento del paziente affetto da carcinoma del colon-retto
2. Quality-of-life assessment in colorectal cancer patients: Evaluation of cancer therapies
3. Reliability and validity of the functional assessment of cancer therapy-colorectal (FACT-C) quality of life instrument
4. The construction and testing of the EORTC colorectal cancer-specific quality of life questionnaire-module (QLQ-CR38)
5. Effect of regional and systemic fluorinated pyrimidine chemotherapy on quality of life in colorectal liver metastases patients
6. Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases
7. A randomized, double-blind trial of fluorouracil plus placebo versus fluorouracil plus oral leucovorin in patients with metastatic colorectal cancer
8. Randomized trial assessing the addition of interferon alfa-2a to fluorouracil and leucovorin in advanced colorectal cancer
9. Impact of protracted venous infusion fluorouracil with or without interferon alfa-2b on tumor response, survival and quality of life in advanced colorectal cancer
10. A prospective randomized trial of protracted infusion 5-fluorouracil with or without mitomycin C in advanced colorectal cancer
11. Relation between tumor size, quality of life and survival in patients with colorectal liver metastases
12. A survey of patients' perceptions of the convenience of different chemotherapy regimens for advanced colorectal cancer
13. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: A multicentre randomized trial
14. A randomized trial of leucovorin and 5-fluorouracil with or without oxaliplatin in advanced colorectal cancer
15. GIVIO = SITAC-01: A randomized trial of adjuvant 5-fluorouracil and folinic acid administered to patients with colon carcinoma: Long-term result and evaluation of the indicators of health-related quality of life
16. A quality-adjusted time without symptoms or toxicity (Q-TWiST) analysis of adjuvant radiation therapy and chemotherapy for resectable rectal cancer
17. Preoperative chemotherapy of locally advanced gastric cancer
18. Intensive weekly chemotherapy for locally advanced gastric cancer using 5-fluorouracil, cisplatin, epidoxorubicin, 6S-leucovorin, glutathione and filgrastim: A report from the Italian Group for the Study of Digestive (GISCAD)
19. New developments in the treatment of gastric carcinoma
20. Epirubicin, etoposide and cisplatin in the treatment of locally advanced nonresectable gastric carcinoma results of a multicentric pilot study
21. Chemotherapy and surgery for locally advanced cancer of the cardia and fundus: Phase II study with methotrexate and 5-fluorouracil
22. Neoadjuvant chemotherapy for locally advanced gastric cancer: A phase II study with etoposide, adriamycin and cisplatin
23. Epirubicin, cisplatin and continuous infusion 5-fluorouracil (ECF) as neoadjuvant chemotherapy in gastro-oesophageal cancer
24. Medical management of advanced gastric cancer
25. Randomised comparison of fluororuacil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non resectable gastric cancer
26. Modified therapy with 5-fluorouracil, doxorubicin and methotrexate in advanced gastric cancer
27. Initial or delayed chemotherapy with best supportive care in advanced gastric cancer
28. Results of a randomized trial comparing ECF with MCF in advanced oesophago-gastric cancer
29. Chemotherapy in advanced pancreatic adenocarcinoma
30. Chemotherapy prolongs survival in inoperable pancreatic cancer
31. Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer
32. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer
33. Evaluation of clinical benefit of chemotherapy in patients with upper gastrointestinal cancer
34. Development of a disease specific quality of life questionnaire module to supplement the EORTC core cancer QL questionnaire, the QLQ-C30 in patients with pancreatic cancer
35. Cost-effectiveness of palliative chemotherapy in advanced gastrointestinal cancer
36. A new prognostic system for hepatocellular carcinoma: A retrospective study of 435 patients
37. Survival after liver transplantation in cirrhotic patients with and without hepatocellular carcinoma: A comparative study
38. Treatment of hepatocellular carcinoma: A systematic review of randomized controlled trials
39. Prospective validation of the CLIP score: A new prognostic system for patients with cirrhosis and hepatocellular carcinoma
40. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis
41. The effect of the volume of procedures at transplantation centers on mortality after liver transplantation
42. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: Resection versus transplantation
43. Resection of hepatocellular carcinomas: Results in 72 European patients with cirrhosis
44. Surgical experience with 168 primary liver cell carcinomas treated with hepatic resection
45. Hepatocellular carcinoma and cirrhosis. Results of surgical treatment in a European series
46. Should hepatomas be treated with hepatic resection or transplantation?
47. Percutaneous ethanol injection for the treatment of small hepatocellular carcinoma: Study of 95 patients
48. Prospective randomized controlled trial comparing percutaneous acetic acid injection and percutaneous ethanol injection for small hepatocellular carcinoma
49. Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: Results in 123 patients
50. Intraoperative radiofrequency ablation or cryoablation for hepatic malignancies
51. Treatment of small hepatocellular carcinoma in cirrhotic patients: A cohort study comparing surgical resection and percutaneous ethanol injection
52. No treatment, resection and ethanol injection in hepatocellular carcinoma: A retrospective analysis of survival in 391 patients with cirrhosis
53. Hepatocellular carcinoma and cirrhosis in 746 patients: Long-term results of percutaneous ethanol injection
54. A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma
55. Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: Results of a randomized, controlled trial in a single institution
56. Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis
57. Quality of Life (QOL)-focused randomized clinical trial in the treatment of 113 hepatocellular carcinoma (HCC) patients in Zimbabwe: A collaborative study